Manganese superoxide dismutase and oxidative stress modulation

Advances in Clinical Chemistry

Volumn 68, Issue , 2015, Pages 87-130

  Bresciani, Guilherme ^a   da Cruz, Ivana Beatrice Mânica ^b   González Gallego, Javier ^c  

^a UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c UNIVERSITY OF LEÓN   (Spain)

Author keywords

Diseases; Environmental factors; MnSOD; Oxidative stress; SNP; Translational and posttranslational modulation

Indexed keywords

REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

EXERCISE; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EXERCISE; GENETICS; HUMANS; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84964277241     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.acc.2014.11.001     Document Type: Chapter

References (277)

1. Johnson P. Antioxidant enzyme expression in health and disease: effects of exercise and hypertension. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2002, 133:493-505.
2. Cai Q., Shu X.O., Wen W., Cheng J.R., Dai Q., Gao Y.T., Zheng W. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res. 2004, 6:R647-R655.
3. Sen C.K. Antioxidant and redox regulation of cellular signaling: introduction. Med. Sci. Sports Exerc. 2001, 33:368-370.
4. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973, 134:707-716.
5. Triantaphylides C., Havaux M. Singlet oxygen in plants: production, detoxification and signaling. Trends Plant Sci. 2009, 14:219-228.
6. Ji L.L., Gomez-Cabrera M.C., Vina J. Role of nuclear factor kappaB and mitogen-activated protein kinase signaling in exercise-induced antioxidant enzyme adaptation. Appl. Physiol. Nutr. Metab. 2007, 32:930-935.
7. Czaja M.J. Cell signaling in oxidative stress-induced liver injury. Semin. Liver Dis. 2007, 27:378-389.
8. Saberi B., Shinohara M., Ybanez M.D., Hanawa N., Gaarde W.A., Kaplowitz N., Han D. Regulation of H(2)O(2)-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes. Am. J. Physiol. Cell Physiol. 2008, 295:C50-C63.
9. Alessio H.M., Hagerman A.E., Fulkerson B.K., Ambrose J., Rice R.E., Wiley R.L. Generation of reactive oxygen species after exhaustive aerobic and isometric exercise. Med. Sci. Sports Exerc. 2000, 32:1576-1581.
10. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
11. Sam F., Kerstetter D.L., Pimental D.R., Mulukutla S., Tabaee A., Bristow M.R., Colucci W.S., Sawyer D.B. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J. Card. Fail. 2005, 11:473-480.
12. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ. Res. 2010, 107:1058-1070.
13. Kadenbach B., Ramzan R., Vogt S. Degenerative diseases, oxidative stress and cytochrome c oxidase function. Trends Mol. Med. 2009, 15:139-147.
14. Powers S.K., Duarte J., Kavazis A.N., Talbert E.E. Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp. Physiol. 2010, 95:1-9.
15. Pourova J., Kottova M., Voprsalova M., Pour M. Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol (Oxf.) 2010, 198:15-35.
16. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24:981-990.
17. Commoner B., Townsend J., Pake G.E. Free radicals in biological materials. Nature 1954, 174:689-691.
18. Margaritis I., Rousseau A.S. Does physical exercise modify antioxidant requirements?. Nutr. Res. Rev. 2008, 21:3-12.
19. Judge S., Leeuwenburgh C. Cardiac mitochondrial bioenergetics, oxidative stress, and aging. Am. J. Physiol. Cell Physiol. 2007, 292:C1983-C1992.
20. Lopez-Lluch G., Irusta P.M., Navas P., de Cabo R. Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 2008, 43:813-819.
21. Zhang D.X., Gutterman D.D. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2023-H2031.
22. Zalba G., San Jose G., Moreno M.U., Fortuno M.A., Fortuno A., Beaumont F.J., Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001, 38:1395-1399.
23. Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 2011, 50:567-575.
24. Codoner-Franch P., Tavarez-Alonso S., Murria-Estal R., Tortajada-Girbes M., Simo-Jorda R., Alonso-Iglesias E. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children. Nutr. Metab. Cardiovasc. Dis. 2012, 22:237-243.
25. Nunomura A., Honda K., Takeda A., Hirai K., Zhu X., Smith M.A., Perry G. Oxidative damage to RNA in neurodegenerative diseases. J. Biomed. Biotechnol. 2006, 2006:82323.
26. Higgins G.C., Beart P.M., Shin Y.S., Chen M.J., Cheung N.S., Nagley P. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J. Alzheimers Dis. 2010, 20(Suppl. 2):S453-S473.
27. Correia S.C., Santos R.X., Perry G., Zhu X., Moreira P.I., Smith M.A. Mitochondria: the missing link between preconditioning and neuroprotection. J. Alzheimers Dis. 2010, 20(Suppl. 2):S475-S485.
28. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 2005, 58:495-505.
29. Mattson M.P., Gleichmann M., Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
30. Pessayre D. Role of mitochondria in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2007, 22(Suppl. 1):S20-S27.
31. Sachdev S., Davies K.J. Production, detection, and adaptive responses to free radicals in exercise. Free Radic. Biol. Med. 2008, 44:215-223.
32. Ambrosone C.B., Freudenheim J.L., Thompson P.A., Bowman E., Vena J.E., Marshall J.R., Graham S., Laughlin R., Nemoto T., Shields P.G. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999, 59:602-606.
33. Wallace D.C., Melov S. Radicals r'aging. Nat. Genet. 1998, 19:105-106.
34. Edeas M. Strategies to target mitochondria and oxidative stress by antioxidants: key points and perspectives. Pharm. Res. 2011, 28:2771-2779.
35. Finaud J., Lac G., Filaire E. Oxidative stress: relationship with exercise and training. Sports Med. 2006, 36:327-358.
36. Vurusaner B., Poli G., Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic. Biol. Med. 2012, 52:7-18.
37. Leeuwenburgh C., Heinecke J.W. Oxidative stress and antioxidants in exercise. Curr. Med. Chem. 2001, 8:829-838.
38. Tao R.R., Ji Y.L., Lu Y.M., Fukunaga K., Han F. Targeting nitrosative stress for neurovascular protection: new implications in brain diseases. Curr. Drug Targets 2012, 13:272-284.
39. Afanas'ev I. ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?. Oxid. Med. Cell. Longev. 2011, 2011:293769.
40. Stadler K. Peroxynitrite-driven mechanisms in diabetes and insulin resistance-the latest advances. Curr. Med. Chem. 2011, 18:280-290.
41. Zhong W., Oberley L.W., Oberley T.D., St Clair D.K. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 1997, 14:481-490.
42. Mates J.M., Segura J.M., Perez-Gomez C., Rosado R., Olalla L., Blanca M., Sanchez-Jimenez F.M. Antioxidant enzymatic activities in human blood cells after an allergic reaction to pollen or house dust mite. Blood Cells Mol. Dis. 1999, 25:103-109.
43. Kannan K., Jain S.K. Oxidative stress and apoptosis. Pathophysiology 2000, 7:153-163.
44. Landmesser U., Harrison D.G. Oxidant stress as a marker for cardiovascular events: Ox marks the spot. Circulation 2001, 104:2638-2640.
45. Milei J., Forcada P., Fraga C.G., Grana D.R., Iannelli G., Chiariello M., Tritto I., Ambrosio G. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc. Res. 2007, 73:710-719.
46. Garcia J.J., Reiter R.J., Guerrero J.M., Escames G., Yu B.P., Oh C.S., Munoz-Hoyos A. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 1997, 408:297-300.
47. Hennig B., Chow C.K. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic. Biol. Med. 1988, 4:99-106.
48. Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012, 2012:137289.
49. Ercal N., Gurer-Orhan H., Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr. Top. Med. Chem. 2001, 1:529-539.
50. Pivtoraiko V.N., Stone S.L., Roth K.A., Shacka J.J. Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid. Redox Signal. 2009, 11:481-496.
51. Garcia N., Correa F., Chavez E. On the role of the respiratory complex I on membrane permeability transition. J. Bioenerg. Biomembr. 2005, 37:17-23.
52. Venkataraman K., Khurana S., Tai T.C. Oxidative stress in aging-matters of the heart and mind. Int. J. Mol. Sci. 2013, 14:17897-17925.
53. Bollineni R.C., Hoffmann R., Fedorova M. Proteome-wide profiling of carbonylated proteins and carbonylation sites in HeLa cells under mild oxidative stress conditions. Free Radic. Biol. Med. 2014, 68:186-195.
54. Nathan C., Ding A. SnapShot: reactive oxygen intermediates (ROI). Cell 2010, 140. 951-951.e952.
55. Squier T.C. Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 2001, 36:1539-1550.
56. Hitschke K., Buhler R., Apell H.J., Stark G. Inactivation of the Na, K-ATPase by radiation-induced free radicals. Evidence for a radical-chain mechanism. FEBS Lett. 1994, 353:297-300.
57. Muller F.L., Roberts A.G., Bowman M.K., Kramer D.M. Architecture of the Qo site of the cytochrome bc1 complex probed by superoxide production. Biochemistry 2003, 42:6493-6499.
58. Lenaz G., Fato R., Genova M.L., Bergamini C., Bianchi C., Biondi A. Mitochondrial complex I: structural and functional aspects. Biochim. Biophys. Acta 2006, 1757:1406-1420.
59. Lambert A.J., Brand M.D. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J. Biol. Chem. 2004, 279:39414-39420.
60. Smith J.R., Kay N.E., Gottlieb A.J., Oski F.A. Abnormal erythrocyte metabolism in hepatic disease: effect of NADP repletion. Am. J. Hematol. 1979, 6:313-321.
61. Wells P.G., McCallum G.P., Lam K.C., Henderson J.T., Ondovcik S.L. Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits. Birth Defects Res. C Embryo Today 2010, 90:103-109.
62. Mahmoudi M., Mercer J., Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc. Res. 2006, 71:259-268.
63. Chatgilialoglu C., O'Neill P. Free radicals associated with DNA damage. Exp. Gerontol. 2001, 36:1459-1471.
64. Napoli E., Wong S., Giulivi C. Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Mol. Autism 2013, 4:2.
65. Ding Z., Liu S., Wang X., Khaidakov M., Dai Y., Mehta J.L. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci. Rep. 2013, 3:1077.
66. Crawford D.R., Abramova N.E., Davies K.J. Oxidative stress causes a general, calcium-dependent degradation of mitochondrial polynucleotides. Free Radic. Biol. Med. 1998, 25:1106-1111.
67. Gonzalez-Gallego J., Garcia-Mediavilla M.V., Sanchez-Campos S., Tunon M.J. Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 2010, 104(Suppl. 3):S15-S27.
68. Crespo I., Garcia-Mediavilla M.V., Almar M., Gonzalez P., Tunon M.J., Sanchez-Campos S., Gonzalez-Gallego J. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food Chem. Toxicol. 2008, 46:1555-1569.
69. Borrelli A., Schiattarella A., Bonelli P., Tuccillo F.M., Buonaguro F.M., Mancini A. The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD. Biomed. Res. Int. 2014, 2014:476789.
70. Shimizu T., Nojiri H., Kawakami S., Uchiyama S., Shirasawa T. Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S70-S79.
71. Powers S.K., Jackson M.J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol. Rev. 2008, 88:1243-1276.
72. Fransen M., Nordgren M., Wang B., Apanasets O. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim. Biophys. Acta 2012, 1822:1363-1373.
73. Drevet J.R. The antioxidant glutathione peroxidase family and spermatozoa: a complex story. Mol. Cell. Endocrinol. 2006, 250:70-79.
74. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 1999, 27:951-965.
75. Kirkman H.N., Gaetani G.F. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem. Sci. 2007, 32:44-50.
76. Antunes F., Han D., Cadenas E. Relative contributions of heart mitochondria glutathione peroxidase and catalase to H(2)O(2) detoxification in in vivo conditions. Free Radic. Biol. Med. 2002, 33:1260-1267.
77. Culotta V.C., Yang M., O'Halloran T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim. Biophys. Acta 2006, 1763:747-758.
78. Qin Z., Reszka K.J., Fukai T., Weintraub N.L. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl. Res. 2008, 151:68-78.
79. Mancuso R., Osta R., Navarro X. Pre-symptomatic electrophysiological tests predict clinical onset and survival in SOD1 ALS mice. Muscle Nerve 2014, 50:943-949.
80. Yang H., Wang G., Sun H., Shu R., Liu T., Wang C.E., Liu Z., Zhao Y., Zhao B., Ouyang Z., Yang D., Huang J., Zhou Y., Li S., Jiang X., Xiao Z., Li X.J., Lai L. Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res. 2014, 24:464-481.
81. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler. Thromb. Vasc. Biol. 2006, 26:689-695.
82. Oshikawa J., Urao N., Kim H.W., Kaplan N., Razvi M., McKinney R., Poole L.B., Fukai T., Ushio-Fukai M. Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One 2010, 5:e10189.
83. Strassburger M., Bloch W., Sulyok S., Schuller J., Keist A.F., Schmidt A., Wenk J., Peters T., Wlaschek M., Lenart J., Krieg T., Hafner M., Kumin A., Werner S., Muller W., Scharffetter-Kochanek K. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic. Biol. Med. 2005, 38:1458-1470.
84. Dhar S.K., Tangpong J., Chaiswing L., Oberley T.D., St Clair D.K. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 2011, 71:6684-6695.
85. Lebovitz R.M., Zhang H., Vogel H., Cartwright J., Dionne L., Lu N., Huang S., Matzuk M.M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. U.S.A 1996, 93:9782-9787.
86. Williams M.D., Van Remmen H., Conrad C.C., Huang T.T., Epstein C.J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 1998, 273:28510-28515.
87. Van Remmen H., Williams M.D., Guo Z., Estlack L., Yang H., Carlson E.J., Epstein C.J., Huang T.T., Richardson A. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H1422-H1432.
88. Van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., Alderson N.L., Baynes J.W., Epstein C.J., Huang T.T., Nelson J., Strong R., Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 2003, 16:29-37.
89. Miriyala S., Spasojevic I., Tovmasyan A., Salvemini D., Vujaskovic Z., St Clair D., Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim. Biophys. Acta 2012, 1822:794-814.
90. Zhang F., Gu W., Hurles M.E., Lupski J.R. Copy number variation in human health, disease, and evolution. Annu. Rev. Genomics Hum. Genet. 2009, 10:451-481.
91. Wang D.G., Fan J.B., Siao C.J., Berno A., Young P., Sapolsky R., Ghandour G., Perkins N., Winchester E., Spencer J., Kruglyak L., Stein L., Hsie L., Topaloglou T., Hubbell E., Robinson E., Mittmann M., Morris M.S., Shen N., Kilburn D., Rioux J., Nusbaum C., Rozen S., Hudson T.J., Lipshutz R., Chee M., Lander E.S. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998, 280:1077-1082.
92. Sunyaev S., Ramensky V., Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet. 2000, 16:198-200.
93. Crawford A., Fassett R.G., Geraghty D.P., Kunde D.A., Ball M.J., Robertson I.K., Coombes J.S. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 2012, 501:89-103.
94. Forsberg L., de Faire U., Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch. Biochem. Biophys. 2001, 389:84-93.
95. Dawson E. SNP maps: more markers needed?. Mol. Med. Today 1999, 5:419-420.
96. Ravn-Haren G., Olsen A., Tjonneland A., Dragsted L.O., Nexo B.A., Wallin H., Overvad K., Raaschou-Nielsen O., Vogel U. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006, 27:820-825.
97. Lightfoot T.J., Skibola C.F., Smith A.G., Forrest M.S., Adamson P.J., Morgan G.J., Bracci P.M., Roman E., Smith M.T., Holly E.A. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica 2006, 91:1222-1227.
98. Bag A., Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3298-3305.
99. Ho Y.S., Crapo J.D. Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEBS Lett. 1988, 229:256-260.
100. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem. Biophys. Res. Commun. 1996, 226:561-565.
101. Bresciani G., da Cruz I.B., de Paz J.A., Cuevas M.J., Gonzalez-Gallego J. The MnSOD Ala16Val SNP: relevance to human diseases and interaction with environmental factors. Free Radic. Res. 2013, 47:781-792.
102. Holley A.K., Dhar S.K., Xu Y., St Clair D.K. Manganese superoxide dismutase: beyond life and death. Amino Acids 2012, 42:139-158.
103. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003, 13:145-157.
104. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 1998, 18:687-697.
105. Shen X., Zheng S., Metreveli N.S., Epstein P.N. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006, 55:798-805.
106. Fernandez V., Tapia G., Varela P., Castillo I., Mora C., Moya F., Orellana M., Videla L.A. Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of kappaB-alpha phosphorylation and nuclear factor-kappaB activation. J. Endocrinol. 2005, 186:539-547.
107. Ji L.L. Modulation of skeletal muscle antioxidant defense by exercise: role of redox signaling. Free Radic. Biol. Med. 2008, 44:142-152.
108. Goth L. A new type of inherited catalase deficiencies: its characterization and comparison to the Japanese and Swiss type of acatalasemia. Blood Cells Mol. Dis. 2001, 27:512-517.
109. French J.P., Hamilton K.L., Quindry J.C., Lee Y., Upchurch P.A., Powers S.K. Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain. FASEB J. 2008, 22:2862-2871.
110. Kanwar M., Chan P.S., Kern T.S., Kowluru R.A. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 2007, 48:3805-3811.
111. Goto H., Nishikawa T., Sonoda K., Kondo T., Kukidome D., Fujisawa K., Yamashiro T., Motoshima H., Matsumura T., Tsuruzoe K., Araki E. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochem. Biophys. Res. Commun. 2008, 366:814-820.
112. Moreira P.I., Zhu X., Wang X., Lee H.G., Nunomura A., Petersen R.B., Perry G., Smith M.A. Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta 2010, 1802:212-220.
113. Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7:65-74.
114. Safiulina D., Kaasik A. Energetic and dynamic: how mitochondria meet neuronal energy demands. PLoS Biol. 2013, 11:e1001755.
115. Flynn J.M., Melov S. SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic. Biol. Med. 2013, 62:4-12.
116. Zhao Y., Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid. Med. Cell. Longev. 2013, 2013:316523.
117. Padurariu M., Ciobica A., Lefter R., Serban I.L., Stefanescu C., Chirita R. The oxidative stress hypothesis in Alzheimer's disease. Psychiatr. Danub. 2013, 25:401-409.
118. Crichton G.E., Bryan J., Murphy K.J. Dietary antioxidants, cognitive function and dementia-a systematic review. Plant Foods Hum. Nutr. 2013, 68:279-292.
119. De Leo M.E., Borrello S., Passantino M., Palazzotti B., Mordente A., Daniele A., Filippini V., Galeotti T., Masullo C. Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci. Lett. 1998, 250:173-176.
120. Swomley A.M., Forster S., Keeney J.T., Triplett J., Zhang Z., Sultana R., Butterfield D.A. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim. Biophys. Acta 2013, 1842:1248-1257.
121. Ansari M.A., Scheff S.W. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic. Biol. Med. 2011, 51:171-178.
122. Guix F.X., Wahle T., Vennekens K., Snellinx A., Chavez-Gutierrez L., Ill-Raga G., Ramos-Fernandez E., Guardia-Laguarta C., Lleo A., Arimon M., Berezovska O., Munoz F.J., Dotti C.G., De Strooper B. Modification of gamma-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO Mol. Med. 2012, 4:660-673.
123. Greenough M.A., Camakaris J., Bush A.I. Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem. Int. 2013, 62:540-555.
124. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345:91-104.
125. Wiener H.W., Perry R.T., Chen Z., Harrell L.E., Go R.C. A polymorphism in SOD2 is associated with development of Alzheimer's disease. Genes Brain Behav. 2007, 6:770-775.
126. Hong G.S., Heun R., Jessen F., Popp J., Hentschel F., Kelemen P., Schulz A., Maier W., Kolsch H. Gene variations in GSTM3 are a risk factor for Alzheimer's disease. Neurobiol. Aging 2009, 30:691-696.
127. Maes O.C., Schipper H.M., Chong G., Chertkow H.M., Wang E. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease. Neurobiol. Aging 2010, 31:34-45.
128. Hwang O. Role of oxidative stress in Parkinson's disease. Exp. Neurobiol. 2013, 22:11-17.
129. Yamaguchi H., Shen J. Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice. Mol. Neurodegener. 2007, 2:10.
130. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T.M., Dawson V.L. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. U.S.A 2007, 104:14807-14812.
131. Koh H., Kim H., Kim M.J., Park J., Lee H.J., Chung J. Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant. J. Biol. Chem. 2012, 287:12750-12758.
132. Wang V., Chen S.Y., Chuang T.C., Shan D.E., Soong B.W., Kao M.C. Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson's disease. Clin. Biochem. 2010, 43:979-982.
133. Singh M., Khan A.J., Shah P.P., Shukla R., Khanna V.K., Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol. Cell. Biochem. 2008, 312:131-138.
134. Grasbon-Frodl E.M., Kosel S., Riess O., Muller U., Mehraein P., Graeber M.B. Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem. Biophys. Res. Commun. 1999, 255:749-752.
135. Fong C.S., Wu R.M., Shieh J.C., Chao Y.T., Fu Y.P., Kuao C.L., Cheng C.W. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. Clin. Chim. Acta 2007, 378:136-141.
136. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
137. Jaffer H., Morris V.B., Stewart D., Labhasetwar V. Advances in stroke therapy. Drug Deliv. Transl. Res. 2011, 1:409-419.
138. Mehta S.L., Lin Y., Chen W., Yu F., Cao L., He Q., Chan P.H., Li P.A. Manganese superoxide dismutase deficiency exacerbates ischemic brain damage under hyperglycemic conditions by altering autophagy. Transl. Stroke Res. 2011, 2:42-50.
139. Huang H.F., Guo F., Cao Y.Z., Shi W., Xia Q. Neuroprotection by manganese superoxide dismutase (MnSOD) mimics: antioxidant effect and oxidative stress regulation in acute experimental stroke. CNS Neurosci. Ther. 2012, 18:811-818.
140. Rao A.V., Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 2002, 5:291-309.
141. Yao J.K., Reddy R.D., van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 2001, 15:287-310.
142. Melamed Y., Sirota P., Dicker D.R., Fishman P. Superoxide anion production by neutrophils derived from peripheral blood of schizophrenic patients. Psychiatry Res. 1998, 77:29-34.
143. Sirota P., Gavrieli R., Wolach B. Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity. Psychiatry Res. 2003, 121:123-132.
144. Flatow J., Buckley P., Miller B.J. Meta-analysis of oxidative stress in schizophrenia. Biol. Psychiatry 2013, 74:400-409.
145. Tsai M.C., Liou C.W., Lin T.K., Lin I.M., Huang T.L. Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs. Psychiatry Res. 2013, 209:284-290.
146. Zhang X.Y., Chen da C., Xiu M.H., Yang F.D., Tan Y., Luo X., Zuo L., Kosten T.A., Kosten T.R. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls. Schizophr. Bull. 2014, 40:592-601.
147. Greenlund L.J., Deckwerth T.L., Johnson E.M. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995, 14:303-315.
148. Song C., Killeen A.A., Leonard B.E. Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride. Neuropsychobiology 1994, 30:24-28.
149. Xu H., Luo C., Richardson J.S., Li X.M. Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenomics J. 2004, 4:322-331.
150. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol. 2007, 22:67-73.
151. Selek S., Savas H.A., Gergerlioglu H.S., Bulbul F., Uz E., Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J. Affect. Disord. 2008, 107:89-94.
152. Galecki P., Smigielski J., Florkowski A., Bobinska K., Pietras T., Szemraj J. Analysis of two polymorphisms of the manganese superoxide dismutase gene (Ile-58Thr and Ala-9Val) in patients with recurrent depressive disorder. Psychiatry Res. 2010, 179:43-46.
153. Cumurcu B.E., Ozyurt H., Ates O., Gul I.G., Demir S., Karlidag R. Analysis of manganese superoxide dismutase (MnSOD: Ala-9Val) and glutathione peroxidase (GSH-Px: Pro 197 Leu) gene polymorphisms in mood disorders. Bosn. J. Basic Med. Sci. 2013, 13:109-113.
154. Mansouri A., Tarhuni A., Larosche I., Reyl-Desmars F., Demeilliers C., Degoul F., Nahon P., Sutton A., Moreau R., Fromenty B., Pessayre D. MnSOD overexpression prevents liver mitochondrial DNA depletion after an alcohol binge but worsens this effect after prolonged alcohol consumption in mice. Dig. Dis. 2010, 28:756-775.
155. Parola M., Robino G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 2001, 35:297-306.
156. Letteron P., Duchatelle V., Berson A., Fromenty B., Fisch C., Degott C., Benhamou J.P., Pessayre D. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut 1993, 34:409-414.
157. Letteron P., Fromenty B., Terris B., Degott C., Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol. 1996, 24:200-208.
158. Emerit I., Serejo F., Filipe P., Youssefi A.Alaoui, Fernandes A., Costa A., Freitas J., Ramalho F., Baptista A., de Moura M.Carneiro Clastogenic factors as biomarkers of oxidative stress in chronic hepatitis C. Digestion 2000, 62:200-207.
159. Jain S.K., Pemberton P.W., Smith A., McMahon R.F., Burrows P.C., Aboutwerat A., Warnes T.W. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J. Hepatol. 2002, 36:805-811.
160. Cotler S.J., Kallwitz E., TenCate V., Bhushan A., Berkes J., Benedetti E., Layden-Almer J., Layden T.J., Valyi-Nagy T., Guzman G. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation. Transplantation 2007, 84:587-591.
161. Valgimigli M., Valgimigli L., Trere D., Gaiani S., Pedulli G.F., Gramantieri L., Bolondi L. Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. Free Radic. Res. 2002, 36:939-948.
162. Bhargava A., Raghuram G.V., Pathak N., Varshney S., Jatawa S.K., Jain D., Mishra P.K. Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic. Biol. Med. 2011, 51:1806-1814.
163. Capone F., Guerriero E., Sorice A., Maio P., Colonna G., Castello G., Costantini S. Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients. Clin. Biochem. 2012, 45:525-529.
164. Boelsterli U.A., Lim P.L. Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity?. Toxicol. Appl. Pharmacol. 2007, 220:92-107.
165. Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 2014, 5:e996.
166. van Gurp M., Festjens N., van Loo G., Saelens X., Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem. Biophys. Res. Commun. 2003, 304:487-497.
167. Saelens X., Festjens N., Vande Walle L., van Gurp M., van Loo G., Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004, 23:2861-2874.
168. Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006, 13:1423-1433.
169. Chen M.F., Mo L.R., Lin R.C., Kuo J.Y., Chang K.K., Liao C., Lu F.J. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic. Biol. Med. 1997, 23:672-679.
170. Westman N.G., Marklund S.L. Copper- and zinc-containing superoxide dismutase and manganese-containing superoxide dismutase in human tissues and human malignant tumors. Cancer Res. 1981, 41:2962-2966.
171. Qadri I., Iwahashi M., Capasso J.M., Hopken M.W., Flores S., Schaack J., Simon F.R. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem. J. 2004, 378:919-928.
172. Clemente C., Elba S., Buongiorno G., Guerra V., D'Attoma B., Orlando A., Russo F. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study. Liver Int. 2007, 27:791-797.
173. Tamai T., Uto H., Takami Y., Oda K., Saishoji A., Hashiguchi M., Kumagai K., Kure T., Mawatari S., Moriuchi A., Oketani M., Ido A., Tsubouchi H. Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma. World J. Gastroenterol. 2011, 17:4890-4898.
174. Fortunato G., Castaldo G., Oriani G., Cerini R., Intrieri M., Molinaro E., Gentile I., Borgia G., Piazza M., Salvatore F., Sacchetti L. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin. Chem. 2001, 47:1696-1700.
175. Koch O.R., De Leo M.E., Borrello S., Palombini G., Galeotti T. Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver. Biochem. Biophys. Res. Commun. 1994, 201:1356-1365.
176. Liochev S.I., Fridovich I. The effects of superoxide dismutase on H2O2 formation. Free Radic. Biol. Med. 2007, 42:1465-1469.
177. McKim S.E., Gabele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., Connor H.D., Mason R.P., Doll M.A., Hein D.W., Arteel G.E. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 2003, 125:1834-1844.
178. Thirunavukkarasu M., Penumathsa S.V., Koneru S., Juhasz B., Zhan L., Otani H., Bagchi D., Das D.K., Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med. 2007, 43:720-729.
179. Kowluru R.A., Atasi L., Ho Y.S. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2006, 47:1594-1599.
180. Naudi A., Jove M., Ayala V., Cassanye A., Serrano J., Gonzalo H., Boada J., Prat J., Portero-Otin M., Pamplona R. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp. Diabetes Res. 2012, 2012:696215.
181. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
182. Ostrow V., Wu S., Aguilar A., Bonner R., Suarez E., De Luca F. Association between oxidative stress and masked hypertension in a multi-ethnic population of obese children and adolescents. J. Pediatr. 2011, 158. 628-633 e621.
183. Molnar D., Decsi T., Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int. J. Obes. Relat. Metab. Disord. 2004, 28:1197-1202.
184. Zhu Y.G., Zhang S.M., Wang J.Y., Xiao W.Q., Wang X.Y., Zhou J.F. Overweight and obesity-induced oxidative stress in children. Biomed. Environ. Sci. 2006, 19:353-359.
185. Schauble N., Reichwald K., Grassl W., Bechstein H., Muller H.C., Scherag A., Geller F., Utting M., Siegfried W., Goldschmidt H., Blundell J., Lawton C., Alam R., Whybrow S., Stubbs J., Platzer M., Hebebrand J., Hinney A. Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity. J. Nutr. 2005, 135:1387-1392.
186. Nomiyama T., Tanaka Y., Piao L., Nagasaka K., Sakai K., Ogihara T., Nakajima K., Watada H., Kawamori R. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J. Hum. Genet. 2003, 48:138-141.
187. Mollsten A., Jorsal A., Lajer M., Vionnet N., Tarnow L. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes. Diabetologia 2009, 52:2590-2593.
188. Mollsten A., Marklund S.L., Wessman M., Svensson M., Forsblom C., Parkkonen M., Brismar K., Groop P.H., Dahlquist G. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 2007, 56:265-269.
189. Strokov I.A., Bursa T.R., Drepa O.I., Zotova E.V., Nosikov V.V., Ametov A.S. Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study. Acta Diabetol. 2003, 40(Suppl. 2):S375-S379.
190. Hovnik T., Dolzan V., Bratina N.U., Podkrajsek K.T., Battelino T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care 2009, 32:2258-2262.
191. Kangas-Kontio T., Vavuli S., Kakko S.J., Penna J., Savolainen E.R., Savolainen M.J., Liinamaa M.J. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br. J. Ophthalmol. 2009, 93:1401-1406.
192. Flekac M., Skrha J., Hilgertova J., Lacinova Z., Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med. Genet. 2008, 9:30.
193. Chen H., Yu M., Li M., Zhao R., Zhu Q., Zhou W., Lu M., Lu Y., Zheng T., Jiang J., Zhao W., Xiang K., Jia W., Liu L. Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease. Mol. Cell. Biochem. 2012, 363:85-91.
194. Duarte M.M., Moresco R.N., Duarte T., Santi A., Bagatini M.D., da Cruz I.B., Schetinger M.R., Loro V.L. Oxidative stress in hypercholesterolemia and its association with Ala16Val superoxide dismutase gene polymorphism. Clin. Biochem. 2010, 43:1118-1123.
195. Montano M.A., Barrio Lera J.P., Gottlieb M.G., Schwanke C.H., da Rocha M.I., Manica-Cattani M.F., dos Santos G.F., da Cruz I.B. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and elderly obesity. Mol. Cell. Biochem. 2009, 328:33-40.
196. Gottlieb M.G., Schwanke C.H., Santos A.F., Jobim P.F., Mussel D.P., da Cruz I.B. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population. Genet. Mol. Res. 2005, 4:691-703.
197. Montano M.A., da Cruz I.B., Duarte M.M., Krewer Cda C., da Rocha M.I., Manica-Cattani M.F., Soares F.A., Rosa G., Maris A.F., Battiston F.G., Trott A., Lera J.P. Inflammatory cytokines in vitro production are associated with Ala16Val superoxide dismutase gene polymorphism of peripheral blood mononuclear cells. Cytokine 2012, 60:30-33.
198. Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid. Redox Signal. 2011, 15:1583-1606.
199. Gongora M.C., Qin Z., Laude K., Kim H.W., McCann L., Folz J.R., Dikalov S., Fukai T., Harrison D.G. Role of extracellular superoxide dismutase in hypertension. Hypertension 2006, 48:473-481.
200. Dieterich S., Bieligk U., Beulich K., Hasenfuss G., Prestle J. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 2000, 101:33-39.
201. Wen J.J., Vyatkina G., Garg N. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic. Biol. Med. 2004, 37:1821-1833.
202. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
203. Kardia S.L., Greene M.T., Boerwinkle E., Turner S.T., Kullo I.J. Investigating the complex genetic architecture of ankle-brachial index, a measure of peripheral arterial disease, in non-Hispanic whites. BMC Med. Genomics 2008, 1:16.
204. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 1999, 85:753-766.
205. Wing L.Y., Chen Y.C., Shih Y.Y., Cheng J.C., Lin Y.J., Jiang M.J. Effects of oral estrogen on aortic ROS-generating and -scavenging enzymes and atherosclerosis in apoE-deficient mice. Exp. Biol. Med. (Maywood) 2009, 234:1037-1046.
206. Araujo J.A., Zhang M., Yin F. Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front. Pharmacol. 2012, 3:119.
207. Kakko S., Paivansalo M., Koistinen P., Kesaniemi Y.A., Kinnula V.L., Savolainen M.J. The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis 2003, 168:147-152.
208. Yuan X.M., Li W., Brunk U.T., Dalen H., Chang Y.H., Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic. Biol. Med. 2000, 28:208-218.
209. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., Reuf J., Horaist C., Lebovitz R., Hunter G.C., McIntyre K., Runge M.S. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
210. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11:376-381.
211. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998, 18:159-163.
212. Melov S., Doctrow S.R., Schneider J.A., Haberson J., Patel M., Coskun P.E., Huffman K., Wallace D.C., Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci. 2001, 21:8348-8353.
213. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.T., Miziorko H., Epstein C.J., Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. U.S.A 1999, 96:846-851.
214. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., Davisson R.L. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 2002, 91:1038-1045.
215. Dikalova A.E., Bikineyeva A.T., Budzyn K., Nazarewicz R.R., McCann L., Lewis W., Harrison D.G., Dikalov S.I. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 2010, 107:106-116.
216. Archer S.L., Marsboom G., Kim G.H., Zhang H.J., Toth P.T., Svensson E.C., Dyck J.R., Gomberg-Maitland M., Thebaud B., Husain A.N., Cipriani N., Rehman J. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 2010, 121:2661-2671.
217. Connor K.M., Subbaram S., Regan K.J., Nelson K.K., Mazurkiewicz J.E., Bartholomew P.J., Aplin A.E., Tai Y.T., Aguirre-Ghiso J., Flores S.C., Melendez J.A. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 2005, 280:16916-16924.
218. Abid M.R., Tsai J.C., Spokes K.C., Deshpande S.S., Irani K., Aird W.C. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J. 2001, 15:2548-2550.
219. Alameddine F.M., Zafari A.M. Genetic polymorphisms and oxidative stress in heart failure. Congest. Heart Fail. 2002, 8:157-164. 172.
220. Givertz M.M., Colucci W.S. New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 1998, 352(Suppl. 1):SI34-SI38.
221. Mallat Z., Philip I., Lebret M., Chatel D., Maclouf J., Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998, 97:1536-1539.
222. Diaz-Velez C.R., Garcia-Castineiras S., Mendoza-Ramos E., Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am. Heart J. 1996, 131:146-152.
223. Keith M., Geranmayegan A., Sole M.J., Kurian R., Robinson A., Omran A.S., Jeejeebhoy K.N. Increased oxidative stress in patients with congestive heart failure. J. Am. Coll. Cardiol. 1998, 31:1352-1356.
224. Hsueh Y.M., Lin P., Chen H.W., Shiue H.S., Chung C.J., Tsai C.T., Huang Y.K., Chiou H.Y., Chen C.J. Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension. J. Toxicol. Environ. Health A 2005, 68:1471-1484.
225. Fujimoto H., Taguchi J., Imai Y., Ayabe S., Hashimoto H., Kobayashi H., Ogasawara K., Aizawa T., Yamakado M., Nagai R., Ohno M. Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur. Heart J. 2008, 29:1267-1274.
226. Fujimoto H., Kobayashi H., Ogasawara K., Yamakado M., Ohno M. Association of the manganese superoxide dismutase polymorphism with vasospastic angina pectoris. J. Cardiol. 2010, 55:205-210.
227. Charniot J.C., Sutton A., Bonnefont-Rousselot D., Cosson C., Khani-Bittar R., Giral P., Charnaux N., Albertini J.P. Manganese superoxide dismutase dimorphism relationship with severity and prognosis in cardiogenic shock due to dilated cardiomyopathy. Free Radic. Res. 2011, 45:379-388.
228. Young R.P., Hopkins R., Black P.N., Eddy C., Wu L., Gamble G.D., Mills G.D., Garrett J.E., Eaton T.E., Rees M.I. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006, 61:394-399.
229. Choi J.Y., Neuhouser M.L., Barnett M., Hudson M., Kristal A.R., Thornquist M., King I.B., Goodman G.E., Ambrosone C.B. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1115-1120.
230. Zejnilovic J., Akev N., Yilmaz H., Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet. Cytogenet. 2009, 189:1-4.
231. Nahon P., Charnaux N., Friand V., Prost-Squarcioni C., Ziol M., Lievre N., Trinchet J.C., Beaugrand M., Gattegno L., Pessayre D., Sutton A. The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells. Free Radic. Biol. Med. 2008, 45:1308-1317.
232. Nahon P., Sutton A., Rufat P., Ziol M., Akouche H., Laguillier C., Charnaux N., Ganne-Carrie N., Grando-Lemaire V., N'Kontchou G., Trinchet J.C., Gattegno L., Pessayre D., Beaugrand M. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 2009, 50:1484-1493.
233. Wang S., Wang F., Shi X., Dai J., Peng Y., Guo X., Wang X., Shen H., Hu Z. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk-a meta-analysis. Eur. J. Cancer 2009, 45:2874-2881.
234. Choi J.Y., Neuhouser M.L., Barnett M.J., Hong C.C., Kristal A.R., Thornquist M.D., King I.B., Goodman G.E., Ambrosone C.B. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 2008, 29:964-970.
235. Caple F., Williams E.A., Spiers A., Tyson J., Burtle B., Daly A.K., Mathers J.C., Hesketh J.E. Inter-individual variation in DNA damage and base excision repair in young, healthy non-smokers: effects of dietary supplementation and genotype. Br. J. Nutr. 2010, 103:1585-1593.
236. Stroth S., Hille K., Spitzer M., Reinhardt R. Aerobic endurance exercise benefits memory and affect in young adults. Neuropsychol. Rehabil. 2009, 19:223-243.
237. Nader P.R., Bradley R.H., Houts R.M., McRitchie S.L., O'Brien M. Moderate-to-vigorous physical activity from ages 9 to 15 years. JAMA 2008, 300:295-305.
238. Polidori M.C., Mecocci P., Cherubini A., Senin U. Physical activity and oxidative stress during aging. Int. J. Sports Med. 2000, 21:154-157.
239. Fernandes T., Nakamuta J.S., Magalhaes F.C., Roque F.R., Lavini-Ramos C., Schettert I.T., Coelho V., Krieger J.E., Oliveira E.M. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J. Hypertens. 2012, 30:2133-2143.
240. Blumenthal J.A., Babyak M.A., O'Connor C., Keteyian S., Landzberg J., Howlett J., Kraus W., Gottlieb S., Blackburn G., Swank A., Whellan D.J. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 2012, 308:465-474.
241. Oliveira C., Simoes M., Carvalho J., Ribeiro J. Combined exercise for people with type 2 diabetes mellitus: a systematic review. Diabetes Res. Clin. Pract. 2012, 98:187-198.
242. Davis C.L., Pollock N.K., Waller J.L., Allison J.D., Dennis B.A., Bassali R., Melendez A., Boyle C.A., Gower B.A. Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial. JAMA 2012, 308:1103-1112.
243. Kraus W.E., Slentz C.A. Exercise training, lipid regulation, and insulin action: a tangled web of cause and effect. Obesity (Silver Spring) 2009, 17(Suppl. 3):S21-S26.
244. Fuchsjager-Mayrl G., Pleiner J., Wiesinger G.F., Sieder A.E., Quittan M., Nuhr M.J., Francesconi C., Seit H.P., Francesconi M., Schmetterer L., Wolzt M. Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care 2002, 25:1795-1801.
245. Kadoglou N.P., Fotiadis G., Kapelouzou A., Kostakis A., Liapis C.D., Vrabas I.S. The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes. Diabet. Med. 2013, 30:e41-e50.
246. Green D.J., O'Driscoll G., Joyner M.J., Cable N.T. Exercise and cardiovascular risk reduction: time to update the rationale for exercise?. J. Appl. Physiol. (1985) 2008, 105:766-768.
247. Dimeo F., Pagonas N., Seibert F., Arndt R., Zidek W., Westhoff T.H. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension 2012, 60:653-658.
248. Hansen D., Eijnde B.O., Roelants M., Broekmans T., Rummens J.L., Hensen K., Daniels A., Van Erum M., Bonne K., Reyckers I., Alders T., Berger J., Dendale P. Clinical benefits of the addition of lower extremity low-intensity resistance muscle training to early aerobic endurance training intervention in patients with coronary artery disease: a randomized controlled trial. J. Rehabil. Med. 2011, 43:800-807.
249. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid. Redox Signal. 2011, 15:1911-1926.
250. Powers S.K., Lennon S.L. Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proc. Nutr. Soc. 1999, 58:1025-1033.
251. Gomes E.C., Silva A.N., de Oliveira M.R. Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species. Oxid. Med. Cell. Longev. 2012, 2012:756132.
252. Ohishi S., Kizaki T., Ookawara T., Toshinai K., Haga S., Karasawa F., Satoh T., Nagata N., Ji L.L., Ohno H. The effect of exhaustive exercise on the antioxidant enzyme system in skeletal muscle from calcium-deficient rats. Pflugers Arch. 1998, 435:767-774.
253. Hollander J., Fiebig R., Gore M., Bejma J., Ookawara T., Ohno H., Ji L.L. Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training. Am. J. Physiol. 1999, 277:R856-R862.
254. Hollander J., Bejma J., Ookawara T., Ohno H., Ji L.L. Superoxide dismutase gene expression in skeletal muscle: fiber-specific effect of age. Mech. Ageing Dev. 2000, 116:33-45.
255. Pansarasa O., D'Antona G., Gualea M.R., Marzani B., Pellegrino M.A., Marzatico F. "Oxidative stress": effects of mild endurance training and testosterone treatment on rat gastrocnemius muscle. Eur. J. Appl. Physiol. 2002, 87:550-555.
256. Ookawara T., Haga S., Ha S., Oh-Ishi S., Toshinai K., Kizaki T., Ji L.L., Suzuki K., Ohno H. Effects of endurance training on three superoxide dismutase isoenzymes in human plasma. Free Radic. Res. 2003, 37:713-719.
257. Adhihetty P.J., Taivassalo T., Haller R.G., Walkinshaw D.R., Hood D.A. The effect of training on the expression of mitochondrial biogenesis- and apoptosis-related proteins in skeletal muscle of patients with mtDNA defects. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E672-E680.
258. Morton J.P., Maclaren D.P., Cable N.T., Campbell I.T., Evans L., Kayani A.C., McArdle A., Drust B. Trained men display increased basal heat shock protein content of skeletal muscle. Med. Sci. Sports Exerc. 2008, 40:1255-1262.
259. Ferrara N., Rinaldi B., Corbi G., Conti V., Stiuso P., Boccuti S., Rengo G., Rossi F., Filippelli A. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 2008, 11:139-150.
260. Lawler J.M., Kwak H.B., Kim J.H., Suk M.H. Exercise training inducibility of MnSOD protein expression and activity is retained while reducing prooxidant signaling in the heart of senescent rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R1496-R1502.
261. Xu X., Zhao W., Wan W., Ji L.L., Powers A.S., Erikson J.M., Zhang J.Q. Exercise training combined with angiotensin II receptor blockade reduces oxidative stress after myocardial infarction in rats. Exp. Physiol. 2010, 95:1008-1015.
262. Garcia-Lopez D., Hakkinen K., Cuevas M.J., Lima E., Kauhanen A., Mattila M., Sillanpaa E., Ahtiainen J.P., Karavirta L., Almar M., Gonzalez-Gallego J. Effects of strength and endurance training on antioxidant enzyme gene expression and activity in middle-aged men. Scand. J. Med. Sci. Sports 2007, 17:595-604.
263. Bo H., Jiang N., Ma G., Qu J., Zhang G., Cao D., Wen L., Liu S., Ji L.L., Zhang Y. Regulation of mitochondrial uncoupling respiration during exercise in rat heart: role of reactive oxygen species (ROS) and uncoupling protein 2. Free Radic. Biol. Med. 2008, 44:1373-1381.
264. Spurway N., Wackerhage H. Genetics and Molecular Biology of Muscle Adaptation 2006, Churchill Livingstone, Edinburgh. first ed.
265. Montgomery H.E., Clarkson P., Dollery C.M., Prasad K., Losi M.A., Hemingway H., Statters D., Jubb M., Girvain M., Varnava A., World M., Deanfield J., Talmud P., McEwan J.R., McKenna W.J., Humphries S. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997, 96:741-747.
266. Puthucheary Z., Skipworth J.R., Rawal J., Loosemore M., Van Someren K., Montgomery H.E. The ACE gene and human performance: 12 years on. Sports Med. 2011, 41:433-448.
267. Collins M., Mokone G.G., September A.V., van der Merwe L., Schwellnus M.P. The COL5A1 genotype is associated with range of motion measurements. Scand. J. Med. Sci. Sports 2009, 19:803-810.
268. Posthumus M., Schwellnus M.P., Collins M. The COL5A1 gene: a novel marker of endurance running performance. Med. Sci. Sports Exerc. 2011, 43:584-589.
269. O'Connell K., Posthumus M., Collins M. COL6A1 gene and Ironman triathlon performance. Int. J. Sports Med. 2011, 32:896-901.
270. Lucia A., Gomez-Gallego F., Santiago C., Bandres F., Earnest C., Rabadan M., Alonso J.M., Hoyos J., Cordova A., Villa G., Foster C. ACTN3 genotype in professional endurance cyclists. Int. J. Sports Med. 2006, 27:880-884.
271. Fiuza-Luces C., Ruiz J.R., Rodriguez-Romo G., Santiago C., Gomez-Gallego F., Yvert T., Cano-Nieto A., Garatachea N., Moran M., Lucia A. Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism. PLoS One 2011, 6:e17558.
272. Bouchard C. Genomic predictors of trainability. Exp. Physiol. 2012, 97:347-352.
273. Akimoto A.K., Miranda-Vilela A.L., Alves P.C., Pereira L.C., Lordelo G.S., Hiragi Cde O., da Silva I.C., Grisolia C.K., Klautau-Guimaraes Mde N. Evaluation of gene polymorphisms in exercise-induced oxidative stress and damage. Free Radic. Res. 2010, 44:322-331.
274. Ahmetov I.I., Naumov V.A., Donnikov A.E., Maciejewska-Karłowska A., Kostryukova E.S., Larin A.K., Maykova E.V., Alexeev D.G., Fedotovskaya O.N., Generozov E.V., Jastrzebski Z., Zmijewski P., Kravtsova O.A., Kulemin N.A., Leonska-Duniec A., Martykanova D.S., Ospanova E.A., Pavlenko A.V., Podol'skaya A.A., Sawczuk M., Alimova F.K., Trofimov D.Y., Govorun V.M., Cieszczyk P. SOD2 gene polymorphism and muscle damage markers in elite athletes. Free Radic. Res. 2014, 48:948-955.
275. Bresciani G., Gonzalez-Gallego J., da Cruz I.B., de Paz J.A., Cuevas M.J. The Ala16Val MnSOD gene polymorphism modulates oxidative response to exercise. Clin. Biochem. 2013, 46:335-340.
276. Miranda-Vilela A.L., Akimoto A.K., Alves P.C., Pereira L.C., Goncalves C.A., Klautau-Guimaraes M.N., Grisolia C.K. Dietary carotenoid-rich pequi oil reduces plasma lipid peroxidation and DNA damage in runners and evidence for an association with MnSOD genetic variant -Val9Ala. Genet. Mol. Res. 2009, 8:1481-1495.
277. Miranda-Vilela A.L., Alves P.C., Akimoto A.K., Pereira L.C., Klautau-Guimaraes M.Nazare, Grisolia C.K. The effect of hydrogen peroxide-induced oxidative stress on leukocytes depends on age and physical training in healthy human subjects carrying the same genotypes of antioxidant enzymes' gene polymorphisms. Am. J. Hum. Biol. 2010, 22:807-812.